HOME › DRUGS › LONCASTUXIMAB TESIRINE-LPYL
ACTIVE SUBSTANCE / INN

LONCASTUXIMAB TESIRINE-LPYL

Brand name(s): ZYNLONTA
FDA LISTED
PRESCRIPTION
BLA761196
ACTIVE SUBSTANCE
Loncastuximab Tesirine-Lpyl
REGULATORS
FDA
SPONSORS / MAH
ADC Therapeutics SA
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ZYNLONTABLA761196ADC Therapeutics SAPrescription

FULL INTELLIGENCE ON LONCASTUXIMAB TESIRINE-LPYL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →